Largest disclosed lower bound
Gilbert Ray Cisneros, Jr. · $1.0K–$15.0K
BUY · traded 2026-03-03 → filed 2026-04-07. Ranked over every RARE row by the provable lower bound, never a point estimate.
Public record / Tickers / RARE
RARE — Ultragenyx Pharmaceutical Inc.†
Both disclosure regimes on one name: who in Congress filed about RARE, which institutions reported holding it. Each section keeps its own clock — congressional trades on the 45-day PTR clock, 13F holdings as quarter-end snapshots.
- Congress txns
- 4
- all PTR rows naming RARE
- Members · 12m
- 1
- 2 buys · 0 sells · by trade date
- Latest PTR
- 04-07
- filed 2026-04-07
- 13F holders
- 255
- top-255 slice · 2026-03-31
Congress = transactions in statutory ranges, 45-day lag · Institutions = quarter-end positions, 45-day lagas of 2026-10-01 13:54 UTCno price data — a disclosure record, not a chart
Congress · trailing 12 months
1 member · 2 buys / 0 sells
Counts of disclosures by trade date, not dollars — ranges cannot be netted across members. Flow ranges per member are in the table below.
Timeliness
Every row filed inside the 45-day window
Late disclosure is stated on the row, never editorialised. Both dates and the receipt stay on every row.
Congress · disclosure timeline
TRADE DATES · 24M · ▲ BUY ▼ SELL · HEIGHT = LOG LOWER BOUND4 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds.
Trade date, not filing date — the lag lives in the table below. 4 rows placed.
PLANNED institutional holder flow by quarter
Congressional disclosures
ALL PTR ROWS NAMING RARE · SORTED FILED ↓ · STATUTORY RANGES · FILED ≤45D LATEfull congressional view ↗| Filed | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2026-04-07 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 03-03 +35d | $1K–$15K | ||
| 2026-03-09 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 02-18 +19d | $1K–$15K | ||
| 2025-09-12 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 08-08 +35d | $1K–$15K | ||
| 2025-08-14 | Gilbert Ray Cisneros, Jr. D–CA-31 | BUY | Traded 07-15 +30d | $1K–$15K |
Each row shows the trade date and the filing date; the gap between them is the disclosure lag.all 4 ↗
Members active in RARE
12M · NET LOWER BOUND · COMMITTEES AS OF TRADE DATE · SNAPSHOT 2026-10-01| Member | Rows | Net disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point. | Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join. |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D–CA-31 | 2 | $2.0K to $30.0K | 2 |
1 members in the window · counts of disclosures, not dollars.
Congress ↔ notable managers · RARE
who in Congress disclosed purchases or sales beside which notable managers added or trimmedCongress · last 90 days
- Buyers
- 0 — —
- Sellers
- 0 — —
filed 2026-07-03 → 2026-10-01 · totals are statutory ranges
Notable managers · quarter ended 2026-03-31
- Adding
- 0 — $0 held
- Trimming
- 1 Moore Capital Management $3.3M held
NEW + ADD vs TRIM + EXIT, by shares · $ = reported value now, not the change · ULTRAGENYX PHARMACEUTICAL IN
| Date | Who | Change | Size |
|---|---|---|---|
| 2026-05-15 | Moore Capital Management 13F | TRIM | −42,868 sh |
1 newest rows · every row dates by its filing date: a disclosure's, or the 13F's for the quarter · a 13F row is a quarter-end snapshot, not a trade
Institutional holders · 13F · Quarter ended 2026-03-31 · longs only
Every one of the 215 13F filers reporting this share class for the quarter is listed. methodology §13F ↗
§ derived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date, which this table does not show, but no document links — the EDGAR link opens the filer's 13F list
n/c Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.
Do the two regimes agree?
TRAILING 12M · CONGRESS vs FILERS NETCongress net (rows)2 buy / 0 sell
Congress net ($ bound)$2.0K to $30.0K
Filers net (actions)not in build
Filers net ($ Q/Q)not in build
The filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.
Signals on RARE
RETAINED WINDOW · ACTIVE HITSZero hits on RARE in the retained window — a computed answer over every rule, not missing coverage.
Planned modules for RARE · financials and macro
Financials — as filed PLANNED
RARE's as-reported XBRL fundamentals will appear here when the financials module passes its gates. Until then: RARE on EDGAR ↗
Macro context PLANNED
Rates, inflation, and positioning series land here with the macro module — vintage-aware, never nowcast.
† issuer name from the SEC's present-day ticker file (company_tickers.json) — a present-day mapping, not the name as of each filing